lost from genetic mosaics (Figure ) , indicating that cell survival in vivo is competitive, especially in rapidly growing tissues, and is influenced by the genotype of nearby cells. Quantitative studies established that the rate of proliferation and survival of Rp/+ cells was diminished when near wild-type neighbors.
One striking observation that emphasized that it is not the absolute fitness of Rp/+ cells but their relative fitness that causes cell competition was that clones of Rp/+ cells could be rescued by starving the animals. It appears paradoxical that an effect of reduced protein synthesis could be suppressed by reduced food supply but it seems ribosomes are not limiting for growth during starvation, so the difference between Rp/+ and wild-type cells disappears.
The next unambiguous example of cell competition was that of cells carrying different doses of the myc proto-oncogene. Although some hypomorphic myc mutants are viable as homozygotes, cells of such genotypes are outcompeted
Cell competition Nicholas E. Baker
It is self-evident that cell-cell interactions play important roles in multicellular organisms. Genetic mosaics and chimeras, containing cells of distinct genotypes, have long provided an important way to identify and study these interactions. Beginning in the 970s, genetic mosaic studies in Drosophila began to reveal an unexpected and intriguing phenomenon called 'cell competition', in which otherwise viable cells could be eliminated if their neighbors were different (Figure ) . Cell competition suggests that the properties of individual cells are monitored during development and that variant clones of progenitor cells can be favored or eliminated accordingly. Interest is now building in the mechanisms of cell competition, how it may be adaptive, and whether cell competition is involved in cancer and other diseases. In recent years, progress has been made in understanding the mechanisms of cell competition through several approaches, although much still remains to be learned. In another example, surprisingly it is the potential tumor cells that are subject to cell competition. Loss of both copies of any of the three apical-basal polarity genes discs large (dlg), scribble (scrib) or lethal-giant larvae (lgl) leads to transformation of the imaginal discs of adult progenitor cells into neoplastic tumors that invade and kill the larvae. By contrast, when these mutations are homozygous in mosaics, they are eliminated without forming tumors. The elimination of these cells is therefore competitive, since it does not occur in the homotypic environment.
Discovery of cell competition

Other features of cell competition
It would be helpful to have more flexible definitions of cell competition, as the measurement and comparison of homotypic and heterotypic growth rates can be problematic. Is nonautonomous induction of cell death an indication of cell competition? In both the Minute and myc studies, outcompeted cells are lost by a caspase-dependent process of apoptosis, and the killing of nearby cells was the first indication that cells carrying mutations in the SWH pathway might be supercompetitors ( Figure ) . Although one can envisage circumstances in which cell death does not result in a net decrease in clonal growth, non-autonomous cell death is clearly a competitive effect of some kind, and so far has correlated well with true cell competition. Now that the expression of specific genes is being correlated with cell competition (see below), this may also provide a useful surrogate test to identify cell competition.
Is cell competition always associated with differential growth? More rapidly growing cells are winners in the case of Minute mutants and myc gene dose, but is this a requirement for cell competition? It is already known that genotypes that change growth cell-autonomously do not always change the growth of their neighbors i.e. cause cell competition. Theoretically, one could also envisage a supercompetitor genotype that grew more slowly than wild type, although no such situation has yet been described. In some other examples, it is the tumor cells that are outcompeted. There are other cases of mammalian cell competition for which the genetic basis is not known. Oertel, Shafritz and colleagues have described an example involving liver repopulation in rats. Chimeric livers can be made by transplantation of fetal liver progenitor cells into hosts. If liver regeneration is later stimulated, for example by partial hepatectomy, the cells derived from the younger donors not only respond more vigorously, but continue proliferating after liver size has been restored, and eliminate host cells by apoptosis until an entirely donor-derived liver is generated. Since the donor cells are wild type, and would survive in nonmosaics, this clearly qualifies as cell competition: the key distinction from the previous examples is that these supercompetitor cells differ by biological age, not genotype.
Cell competition in mammals
Somewhat similar phenomena have been reported in the mouse hematopoietic system. After low-level irradiation of chimeric mice, hematopoietic stem cells with a lower p53 gene dose or activity expand disproportionately, apparently because senescence disproportionately affects cells that express higher levels of p53. The interpretation presented is that the activity of p53 in response to irradiation or other stresses may create a cell that is targeted for senescence more effectively when less-stressed competitors are present. Not all the genes upregulated by outcompeted cells participate in their elimination. The increased expression of Sparc, a multifunctional, secreted glycoprotein, that is observed during cell competition protects against cell death, and suggests that cell competition is a steady, reversible process, perhaps in order not to eliminate cells in response to inconsequential short-term fluctuations in gene expression (Figure 2 ). Because Sparc is secreted, it might also act to limit cell competition spatially.
Mechanisms of cell competition
Common or distinct pathways?
The discovery of genes such as fwe and sparc that react similarly whether there is a confrontation between cells differing in myc or Rp gene dose suggests that there might be a single common pathway of cell competition downstream of diverse initiating stimuli. This question remains unresolved ( Figure  2 ). On the one hand, cross-talk occurs between several competition pathways. Thus, mutations in lgl reduce myc expression, as do mutations in yki, so that, in these examples of cell competition, the competitive outcome always correlates with Myc level. Meanwhile, lgl and scrib also affect SWH signaling. On the other hand, cells with different levels of yki still compete when their Myc expression levels are equalized, suggesting an independent mechanism, and cells with different Rp gene dose exhibit no detectable changes in Yki or Myc levels. Either Rp gene dose causes cell competition through a pathway parallel to Yki, Myc and neoplastic tumor suppressors, or ribosome activity is the most downstream element of all these pathways and the ultimate effector in cell competition. At least four genetic conditions lead to cell competition in Drosophila. These include haploinsufficiency for any of many Rp genes (i.e. Minute mutants), inequality in myc gene dose, mutation of neoplastic tumor suppressors such as Lgl, and activity of the SWH pathway that regulates Yki. How related the molecular mechanisms are is not yet clear. Rp/+ cells trigger engulfment, which is required for their removal. Engulfment is also seen when myc gene dose is unequal, but it is not known how important it is; whether lgl mutant cells are engulfed has not been studied. Both Minute and Myc competition lead to expression of Fwe lose isoforms. It is not yet known whether lgl mutants affect Fwe; they seem to be eliminated because they affect activity of the Mahj protein.
All mechanisms that trigger cell competition, as well as engulfment, Fwe lose expression, and mahj loss induce cell death. The competitive cell death pathway is incoherent, because all known cell competition mechanisms also suppress cell death, through Sparc. Cross-regulatory interactions between Myc, Lgl, and Yki suggest that these pathways might converge, but relationships between the SWH pathway and corpse engulfment, or Fwe, Mahj and Sparc, have yet to be investigated.
Cell competition: what is it good for?
One of the most intriguing questions about cell competition is what is its function, i.e. how is cell competition adaptive? When it was first discovered, cell competition was proposed to be a mechanism of growth control, providing homeostatic regulation in the face of variation. This interpretation has been questioned in light of the fact that blocking apoptosis, which should eliminate many forms of cell competition, has little consequence on the size and morphology of tissues formed by imaginal discs. It has been reported that cell death contributes to the reproducibility of organ size, however, suggesting that it may act in conjunction with other size regulatory mechanisms.
It is becoming more popular to think of cell competition as a surveillance mechanism that selects for the 'fittest' cells as organ precursors. Although it is natural to think of increased proliferation as a selfish property of the individual cell that is selected on that basis, this does not make evolutionary sense in multicellular organisms, which are clonal. Somatic cells can differ genetically through somatic mutation, and there may also be a possibility of epigenetic errors, but such differences should not be subject to natural selection unless they involve the germline. It makes most sense, therefore, to think that, if cell competition is adaptive, it probably acts by increasing organismal fitness via maximization of the quality of somatic cells. In the case of cells mutated for neoplastic tumor suppressors, the adaptive advantage of eliminating tumors that would otherwise be lethal to the fly is evident. The fact that cell competition might promote cancer, for example by selecting for cells expressing higher levels of myc, might be considered to be an evolutionarily acceptable tradeoff for selecting better progenitor cells of other genotypes.
Is there any special reason for eliminating Rp/+ cells, other than that they may not grow particularly well, something that would be common to many somatic mutations? One consideration is that, as there are 88 Drosophila genes encoding cytoplasmic ribosomal proteins, 65 of which lead to a haploinsufficient Minute phenotype, the likelihood of Minute cells arising through spontaneous somatic mutation will be higher than for more typical singlecopy genes, and therefore more worthwhile to select against. It has also been suggested that Minute cells may be an indicator of aneuploidy. Because there are many Rp genes, spread randomly around the genome, any significant aneuploidy is quite likely to generate cells with mismatched Rp gene dosage. Thus, recognizing and eliminating such cells might limit the number of aneuploid cells that could otherwise be a substrate for dangerous further genetic changes.
The suggestion that cell competition might guard against epigenetic defects is inspired by the evidence that cell competition can occur between cells with different states of dosage compensation. These arise stochastically in translocation animals with intermediate X:autosome ratios, and competition between these cells influences whether male or female differentiation preponderates. This suggests that cell competition might occur between cells that differ in other respects, for example as a result of an epigenetic error.
Phenomena that are in some ways reminiscent of cell competition are seen in certain stem cells. Some studies find that the stem cell can be usurped and replaced by its sibling when this latter cell has a more favorable genotype, and that a stem cell can even be displaced from the niche by an unrelated cell when the latter is favored. These phenomena differ from classical cell competition in that cell survival is not affected, and it is uncertain whether similar genes are involved. Nevertheless, they further point to the adaptive significance of maintaining optimal pools of precursor cells. In tissues that are not constructed by mechanisms involving stem cells, cell competition may play a similar role to mechanisms that protect the genetic health of stem cells, the importance of which is widely acknowledged.
Cell competition and disease
There is a growing belief that cell competition plays some role in human cancer, based partly on the fact that this process involves myc, lgl, dlg, scrib, and Sparc, whose vertebrate homologs are known oncogenes or tumor suppressors, and on the fact that most tumors differ genetically from surrounding normal tissue. The first thought is that cell competition would generally favor the expansion of tumors, but it is quite plausible that cell competition can act in anti-tumor surveillance, as occurs with neoplastic tumor genotypes in Drosophila. It is also possible that extrusion of outcompeted cells from epithelia may result in their destruction in some circumstances, but represent a step towards metastasis in others. There is not yet hard evidence for any of these possibilities. It is hard to know how much of myc's contributions to cancer, for example, should be attributed to cell competition rather than its other cancer-promoting effects. This will be easier to assess when there are mutations or treatments that specifically affect cell competition, as their effects on tumorigenesis could then be analyzed.
If cell competition is important in growth control and in optimizing progenitor cell fitness, as argued above, then defects in cell competition might contribute to the frequency or penetrance of other diseases as well. Aside from its normal roles, and potential contribution to disease, cell competition also has possible implications for regenerative medicine and stem cell therapies. Perhaps liver transplantation could be made more efficient, for example, by incorporating competitive mechanisms into liver repopulation and replacement.
Concluding remarks
Clearly, there are many opportunities here to connect the molecular pathways of cell competition, to uncover new ones, and to define the adaptive roles of cell competition. Furture research will address how Fwe expression is triggered, and examine how Fwe, Sparc, Mahj, engulfment factors and other proteins execute competitive cell death, as well as identify their possible relationships to the phenomena reported in liver repopulation and in the hematopoietic system. Some of these gaps may be filled in by forward genetic screens to identify components of cell competition, or by exploiting the cell competition phenomena that have now been reported using cultured cells from Drosophila and mammals.
